Reaction
Intestinal Sepsis reporting signals
As of the last recalculation, Intestinal Sepsis appears in 250 FAERS reports alongside 11 co-occurring drug terms. The strongest observed disproportionality signal is CANAKINUMAB (PRR 468.7).
Important: FAERS is a spontaneous, voluntary, unverified reporting system. PRR and ROR identify reporting patterns for investigation; they are not incidence rates and do not establish causation.
| Drug | Co-reports | PRR | ROR |
|---|---|---|---|
| Canakinumab | 49 | 468.7 | 470.9 |
| Anakinra | 50 | 313.4 | 314.4 |
| Minocycline | 35 | 290.5 | 291.4 |
| Sulfasalazine | 75 | 113.6 | 113.7 |
| Doxyclycline Hyclate | 19 | 100.5 | 100.6 |
| Hydroxychloroquine | 65 | 97.6 | 97.7 |
| Hydroxychloroquine Sulfate | 71 | 90.2 | 90.3 |
| Leflunomide | 75 | 84.8 | 84.9 |
| Tocilizumab | 77 | 80.7 | 80.8 |
| Abatacept | 77 | 66.4 | 66.5 |
| Tofacitinib | 72 | 45.2 | 45.3 |